Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2005 | 12-2004 | |
| Operating Expenses | 2,668 | 731 |
| Operating Income | -2,668 | -731 |
| Other Income | 2,668 | 731 |
| Net Income Continuous | -2,816 | -790 |
| Net Income | $-2,816 | $-790 |
| EPS Basic Total Ops | -15.50 | -19.96 |
| EPS Basic Continuous Ops | -15.50 | -19.96 |
| EPS Diluted Total Ops | -15.50 | -19.96 |
| EPS Diluted Continuous Ops | -15.50 | -19.96 |
| EBITDA(a) | $-2,432 | $-678 |